drugset / Trial / NCT00206141
Seroquel in Bipolar Depression Versus Lithium
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being carried out to see if quetiapine fumarate (Seroquel) is effective in treating bipolar depression during an 8-week acute phase compared with placebo and lithium, followed by continuation treatment for 26 up to 52 with quetiapine fumarate (Seroquel) compared to placebo.
Timeline
- Start
- 2005-08
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 300 mg | — |
| Subject | Quetiapine | Small molecule | 600 mg | — |